Corporate Performance Highlights – Q3 2026

WELL Health Technologies Corp. (TSX: WELL) reported a mixed set of financial metrics for the third quarter of 2026. The company’s Non‑GAAP earnings per share stood at $0.11, according to a release on Seeking Alpha. While the company did not achieve a positive net income figure, the earnings per share figure indicates a modest improvement in profitability relative to prior periods.

Adjusted EBITDA Growth

The company’s subsidiary, HEALWELL AI Inc. (TSX: AIDX), posted a significant increase in adjusted EBITDA for the quarter ended September 30 2026. Adjusted EBITDA rose from $0.7 million in Q3‑2025 to $1.6 million in Q3‑2026, representing a 144 % year‑over‑year gain. The improvement is attributed to:

  • A 7 % increase in total operating expenses relative to the prior year, resulting in lower overall cost pressure.
  • Expanded commercial activity following the acquisition of Orion Health and subsequent multi‑million‑dollar agreements, notably with Converge Health Iowa to deploy DARWEN‑powered AI solutions across Iowa’s statewide Health Information Exchange.

Revenue and Cash Flow

HEALWELL reported $32.6 million in revenue from continuing operations in Q3‑2026, an increase of 7 % compared with $30.4 million in Q3‑2025. The company also noted a substantial improvement in operating cash flow for the nine months ended September 30 2026, with $5.9 million generated from operating activities versus a cash outflow of $20.1 million in the same period the previous year, an improvement of $26 million.

Canadian Patient Services

WELL Health Technologies Corp. announced record revenue for Q3‑2026, with Canadian patient services achieving an adjusted EBITDA increase of 82 %. This performance enabled the company to reach a $100 million annualized run‑rate milestone one quarter ahead of its plan, as reported by CEO.ca on November 9 2026. The achievement underscores the company’s focus on digitally enabled healthcare services and profitable, accretive growth through mergers and acquisitions.

Market Context

  • Market Cap: CAD 1.08 billion
  • Close Price (2026‑11‑08): CAD 4.25
  • 52‑Week High: CAD 5.19 (2026‑06‑03)
  • 52‑Week Low: CAD 3.58 (2025‑11‑24)
  • Price‑to‑Earnings Ratio: 283.78

WELL Health Technologies Corp. continues to pursue a strategy of integrating AI‑driven solutions into its service portfolio, leveraging partnerships and acquisitions to expand its market reach and enhance operational efficiency.